Leading Aesthetics Group (“LAG”) will combine six high-end clinics of which five are focused on aesthetic medicine and one specialising in hair transplant, with procedures performed across nine locations. The integrated Group will offer a comprehensive high-quality doctor-led suite of non-invasive treatments.
The Group is set to establish itself as a leader within the premium segment of the fragmented non-invasive aesthetics market, whose growth is driven by favourable tailwinds including the increasing social acceptance and awareness of aesthetic treatments, and advancements in care available to general public.
LAG, led by an experienced team, will focus on strategic expansion, via a combination of M&A and site rollouts.
Bencis is a specialist private equity investor focused on mid-market investments across the Netherlands, Germany, and Belgium. Since inception in 1999, Bencis has consolidated its buy-and-build and rollout track record, completing over 80 platform deals and over 330 add-ons.
Tresmares has provided an acquisition financing in respect of Bencis’ acquisition, in addition to capex and an RCF to finance acquisitions/rollout and working capital respectively.
Valentijn Broekhuizen, responsible for capital markets at Bencis said: “At Bencis, we are excited to support LAG in its buy-and-build strategy to sustainably grow and consolidate the fragmented aesthetics market in the Netherlands and beyond. We are very happy to have Tresmares Capital as a financing partner in this journey, where we aim to build a platform for medical excellence, operational synergies, and continuous innovation, shaping the future of high-end aesthetic care.”
Jose Ignacio Dengra, Partner at Tresmares Capital said: “This transaction represents a unique opportunity to consolidate the premium aesthetic medicine market in the Netherlands, with a focus on non-invasive treatments. The Group will be supported by the founder doctors, strong management team and a highly reputed equity investor leaving the business ideally positioned to fulfil its growth ambitions. We are excited to participate in this project, and we are grateful to both Bencis and Nielen Schuman for giving us the opportunity to work together. Tresmares has provided a comprehensive debt package that will allow the Company to focus on its growth strategy.”
Phil Arbour, Managing Partner of Tresmares Capital UK said: “This marks Tresmares’ third transaction in the Netherlands this year and are thrilled to be embarking on this growth journey with Bencis and the LAG. We are also delighted to provide a working capital facility to the Group, therefore acting as a one-stop shop for debt financing on this deal. We look forward to seeing the LAG realise its growth ambitions as we close out this decade.”
About Tresmares:
• Tresmares Capital was originally established in Spain in 2020, and soon became one of the largest independent private capital fund managers in Iberia.
• Tresmares opened its London office in November 2022. The London-based team is responsible for sourcing debt and minority equity investments across the UK, Ireland, Benelux and the Nordics.
• Tresmares has grown into a pan-European investment firm, managing capital commitments in excess of €3.3bn.
• Tresmares’ direct lending strategy is sector-agnostic, targeting fast-growing businesses with €2m to €20m of EBITDA, with a product capability spanning from senior debt (including RCFs and TLA), junior debt and preferred equity. Other Tresmares strategies include Fund Finance and Funds of Funds.
